Additionally, 4T1 tumor bearing mice treated with GW4869, an exosome release blocker, showed reduced tumor burden, likely due to an increase in tumor-infiltrating CD8 + T cells in treated mice compared to controls [47]. This evidence concerns the gene CD8A and neoplasm.